-
Barcelona hit seven in Racing Santander rout
-
US Fed raises rates to tackle 'too high' inflation, irking Trump
-
Amorim's Milan beaten by Benfica, Sunderland make dream European return
-
Man Utd misery mounts after League Cup collapse against Brighton
-
US stocks fall, dollar gains after Fed lifts interest rates
-
Turkey releases 106 protesters, jails more LGBTQ activists
-
Seahawks rule out Darnold for Sunday game at Arizona
-
US Fed raises rates to tackle 'too high' inflation in move sure to rile Trump
-
Mbappe explains Ceuta shirt stance after criticism
-
England were 'waiting for death' in World Cup semi-final defeat: Tuchel
-
Improving Atletico cruise to comfortable win over Osasuna
-
NFL star fined for displaying name of slain Palestinian girl
-
Candidate for UN chief calls for AI regulation akin to nuclear weapons
-
Witsel retires from internationals after 18-year Belgium career
-
O'Neill expects Celtic recovery after Old Firm misery
-
US Fed raises rates to battle inflation in move likely to rile Trump
-
Man City midfield trio backed to emulate Rodri and Silva
-
Fitzpatrick 'not comfortable' over Dubai golf finale
-
'We're losing control,' AI pioneer Yoshua Bengio tells AFP
-
Gaza apartment block collapse kills 21, including 12 children
-
WHO eyes 'encouraging' signs in DRCongo fight against Ebola
-
Gaza apartment block collapse leaves 21 dead
-
Liga boss criticises Real Madrid trio for Ceuta shirt incident
-
US House targets data centers as midterm backlash grows
-
WTA Finals moved to Charlotte from 2027
-
French ex-minister Dati goes on trial in Renault-Nissan corruption case
-
Almost 8,000 excess deaths in France's scorched summer: statistics
-
'Being Heumann' captures joy in fight for disability rights
-
Ex-president's lengthy war crimes sentence shocks Kosovo
-
Retired great Nadal to play in exhibition matches
-
US House faces test on sweeping Russia sanctions bill
-
IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan
-
British PM says to make 'difficult decisions' as inflation rises
-
Watts, Pitt, Cruz to light up Spain's top film festival
-
TotalEnergies pumps up controversy in France with cut-price gas
-
Sweden expels Iran embassy employee over anti-Jewish threats
-
Global fuel price demos: a round-up
-
Toogood Gold's Table Mountain Sits in the Shadow of a Nevada Gold Rush
-
Leverate Launches MCP for Traders to Connect AI Assistants With Trading Platforms
-
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
-
MEXC Launches $1M "Discover Your Wall Street DNA" Campaign to Help Traders Find Their Market Fit
-
'Breathing toxin every day': Indonesians choked by haze feel helpless
-
Emporio Armani names Dario Vitale new creative director
-
Stocks edge higher ahead of US Fed rate call
-
Maresca defends VAR officials after Man City benefit from error
-
Philippines ex-leader Duterte makes first in-person ICC appearance
-
Courts jails LGBTQ activists as Turkey crackdown widens
-
2027 Formula One calendar includes Monaco sprint race
-
French court to hear Depardieu's appeal against rape trial order: sources
-
Palestinians are the real victims, Thunberg tells Ed Sheeran
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
HACKENSACK, NJ / ACCESS Newswire / September 4, 2026 / Champions Oncology, Inc. (CSBR), a global leader in clinically relevant oncology research models and translational solutions, will report its financial and operational results for the quarter ended July 31, 2026, on Thursday, September 10, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 938837. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 54523, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions and innovative data platforms to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper
Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
D.Johnson--AT